Tatva Chintan Pharma Chem Ltd - 543321 - Shareholding for the Period Ended December 31, 2021
Tatva Chintan Pharma Chem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Prior Intimation Of Board Meeting
Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2022 ,inter alia, to consider and approve Pursuant to the Regulation 29 (1) (a) read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we hereby inform you that the Meeting of the Board of Directors of Tatva Chintan Pharma Chem Limited is scheduled to be held on Monday, 17 January, 2022, inter alia to: 1.Consider and approve the unaudited standalone financial results of the Company for the quarter/ nine months ended 31 December, 2021. 2.Consider and approve the unaudited consolidated financial results of the Company for the quarter /nine months ended 31 December 2021. Kindly take the above information on your record. Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Sub:-Compliance Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed Compliance Certificate for the quarter ended 31 December 2021, received from M/s. Link Intime India Private Limited, our Registrar and Share Transfer Agent. Kindly take the above information on your record. Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window
Sub. : Intimation of closure of trading window We would like to inform you that, pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company''s code on prohibition of insider trading, the 'Trading Window' for dealing in the equity shares of the Company shall remain closed for all designated persons and their immediate relatives from 1 January 2022 till the completion of 48 hours after the declaration of un-audited financial results of the Company for the quarter ending on 31 December 2021. Kindly take the above information on your record. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of analyst/institutional investors meeting that the Company would be participating: Date Particulars Type Mode 27 December 2021 East Lane Capital One-on-One Virtual meeting Please note that the above is subject to change, if any. Kindly take the above disclosure on your records. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of analyst/institutional investors meeting that the Company would be participating: Date Particulars Type Mode 27 December 2021 SBI Life Insurance Company Ltd One-on-One Virtual meeting Please note that the above is subject to change, if any. Kindly take the above disclosure on your records. Tatva Chintan Pharma Chem Ltd - 543321 - Outcome Of Board Meeting & Intimation For Appointment Of CFO Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 as amended, we wish to inform that based on recommendation of the Nomination and Remuneration Committee (NRC), the Board of Director of the Company at its meeting held on Friday, 03 December 2021, has appointed Mr Ashok Bothra (Chartered Accountant) as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the Company with effect from 03 December 2021. The disclosure required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with para A of Part A of Schedule III of the said regulations and read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09 September 2015 is enclosed in Annexure-1 Kindly take the above disclosure on your records. Tatva Chintan Pharma Chem Ltd - 543321 - Voluntary Disclosure - Purchase Of Land.
With reference to the above subject, we would like to inform you that as a part of future need, the Company has acquired an industrial land admeasuring 50,399.16 Sq. mtr at Dahej-III GIDC Estate, Bharuch, Gujarat, India. The above land has been acquired from internal accruals only & it will be used on need basis in future. The above disclosure is being made voluntarily for the record of Stock Exchanges. Kindly take the above disclosure on your records. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of analyst/institutional investors meeting that the Company would be participating: Date Particulars Type Mode 06 December 2021 JM Financial One-on-One Virtual meeting Please note that the above shall be subject to changes, if any. Kindly take the above disclosure on your records. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir/Madam, Sub: Intimation of Schedule of Analyst/ Institutional Investor meeting. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of analyst/institutional investors meeting that the Company would be participating: Date Particulars Type Mode 17 November 2021 Dolat Capital One-on-One In Person meeting 17 November 2021 B&K SECURITIES - PERISCOPE INDIA, 2021 : Institutional Investor Conference One-on-One Virtual meeting 17 November 2021 Mr. Sarath Sathkumara One-on-One Virtual meeting 18 November 2021 B&K SECURITIES - PERISCOPE INDIA, 2021 : Institutional Investor Conference One-on-One Virtual meeting 19 November 2021 Narotam Sekhsaria Family Office One-on-One In Person meeting Please note that the above shall be subject to changes, if any. Kindly take the above disclosure on your records.